Dr. Sood is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2825 J St Ste 400
Sacramento, CA 95816Phone+1 916-734-5360Fax+1 916-734-5582
Summary
- Dr. Namita Sood is a pulmonologist in Sacramento,CA. She received her medical degree from University of Tripoli School of Medicine and has been in practice 29 years. She specializes in critical care medicine and pleural disease and is experienced in interstitial lung disease, critical care medicine, and pulmonary vascular disease.
Education & Training
- University of North Carolina HospitalsFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 1999
- University of Missouri-ColumbiaResidency, Internal Medicine, 1992 - 1995
- University of Tripoli School of MedicineClass of 1988
Certifications & Licensure
- CA State Medical License 2020 - 2026
- TX State Medical License 2016 - 2021
- OH State Medical License 2001 - 2018
- NC State Medical License 1996 - 2005
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Best Physicians in America 2016
- Excellence in Teaching 2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2006 May 01
- The Expression and Significance of MiRNA Start of enrollment: 2008 Jul 01
- Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial Start of enrollment: 2010 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 3385 citationsAntithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel ReportClive Kearon, Elie A. Akl, Joseph Ornelas, Allen J. Blaivas, David Jiménez
Chest. 2012-02-01 - 21 citationsMortality in Patients With Pulmonary Arterial Hypertension Treated With Continuous Prostanoids.Sonja Bartolome, Namita Sood, Trushil G. Shah, Kim Styrvoky, Fernando Torres
Chest. 2018-09-01 - 47 citationsCombination therapy with oral treprostinil for pulmonary arterial hypertension: A double-blind placebo-controlled clinical trialR. James White, Carlos Jerjes-Sánchez, Gisela Martina Bohns Meyer, Tomas Pulido, Pablo Sepúlveda
American Journal of Respiratory and Critical Care Medicine. 2020-03-15
Journal Articles
- Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel ReportKearon C, Akl E A, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King C S, Morris T A, Sood N, Stevens S M, Vintch J, Wells P, Woller S C, Moores L, Chest, 1/1/2016
- An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell DiseaseKlings E S, Machado R F, Barst R J, et al, American Journal of Respiratory and Critical Care Medicine, 1/1/2014
- Macitentan for the Treatment of Pulmonary Arterial HypertensionSood N, Expert Opinion On Pharmacotherapy, 1/1/2014
- Join now to see all
Abstracts/Posters
- Hemodynamic Effects of the Oral Prostacyclin (IP) Receptor Agonist Ralinepag in Pulmonary Arterial Hypertension.Sood N, CHEST, 1/1/2017
- Results of the Prospective, Multicenter, Single-Arm, Open-Label, Phase 4 MOTION Study of Riociguat in Pulmonary Arterial HypertensionSoodN, Aranda A, Platt D, La Rose A, O Brien G, ATS, 1/1/2017
- Baseline Demographics of the Prospective, Multicenter, Single-Arm, Open-Label, Phase IV MOTION Study of Riociguat in Pulmonary Arterial HypertensionSoodN, Aranda A, Platt D, Mobin S, O Brien G.Satler C, ATS, 1/1/2016
- Join now to see all
Lectures
- Management of Pulmonary Arterial HypertensionBlanchard Valley Hospital, Findlay, OH, 2008; University of Texas Health Science Center at Houston, - 1/1/2017
- Special Consideration Regarding Altiltude/ Flying / Diving.University of Texas Health Science Center at Houston - 1/1/2017
- Case Studies in Pulmonary vascular DiseaseUniversity of Texas Health Science Center at Houston - 1/1/2017
- Join now to see all
Press Mentions
- Reflecting on CHEST 2021November 1st, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: